Home » Topics » Regulatory » EMA

EMA
RSS

EMA grants orphan designation to REGN-2477 for fibrodysplasia ossificans progressiva

Dec. 16, 2016

CM-4620 receives EMA orphan designation for acute pancreatitis

Dec. 15, 2016

EMA grants UGT1A1 gene therapy orphan designation for Crigler-Najjar syndrome

Dec. 14, 2016

EMA validates Oxervate MAA for neurotrophic keratitis

Dec. 13, 2016

EMA accepts for review MAA for dupilumab in atopic dermatitis

Dec. 9, 2016

EMA committee confirms hepatitis B re-activation risk with direct-acting antivirals for hepatitis C

Dec. 5, 2016

EMA accepts Coherus BioSciences' MAA for pegfilgrastim biosimilar

Nov. 30, 2016

EMA grants full aproval to vismodegib

Nov. 29, 2016

Immunovaccine's DPX-Survivac wins EMA orphan drug designation

Nov. 23, 2016

EMA grants positive opinion for teriparatide biosimilar

Nov. 17, 2016

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...